Research Antibodies & Reagents Market is Expected to Reach $16.2 billion | MarketsandMarkets.

Chicago, Oct. 27, 2023 (GLOBE NEWSWIRE) — The research antibodies and reagents industry is poised for significant growth in the near future, driven by advancing biotechnological research and increasing demand for high-quality tools to support scientific discovery. This sector will witness expanding applications in fields such as genomics, proteomics, and immunology, with a focus on personalized medicine and precision diagnostics. Innovations in monoclonal antibodies, recombinant proteins, and cutting-edge assay kits will enable more targeted and accurate experiments, fostering breakthroughs in healthcare and life sciences. Furthermore, the adoption of automation, AI-driven data analysis, and sustainable practices will shape this industry’s landscape, ensuring its pivotal role in driving scientific progress and therapeutic advancements.

Research Antibodies & Reagents market in terms of revenue was estimated to be worth $11.8 billion in 2023 and is poised to reach $16.2 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. The growth of the market is steered due advancing neurobiology research, with antibodies being used to identify and elucidate cellular, molecular, or biochemical reactions, thus enabling a better understanding of neuroscience processes and neuronal diseases. Also, the availability of R&D funds from organizations for various genomic projects is boosting research in genomics. An increase in research activity and funding availability is expected to drive the purchase and consumption of research antibodies, thus driving overall market growth.

Download an Illustrative overview:

Research Antibodies & Reagents Market Scope:

Report Coverage Details
Market Revenue in 2023 $11.8 billion
Estimated Value by 2028 $16.2 billion
Growth Rate Poised to grow at a CAGR of 6.5%
Market Size Available for 2021-2028
Forecast Period 2023-2028
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Technology, Application, End User
Geographies Covered North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunity High-growth potential of emerging economies
Key Market Driver Rising funding for life science research

Research Antibodies & Reagents market major players covered in the report, such as:

  • Abcam plc (UK)
  • Cell Signaling Technology, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • BD (US)
  • Bio-Rad Laboratories, Inc. (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Agilent Technologies, Inc. (US)
  • Danaher (US)
  • Lonza (Switzerland)
  • GenScript (China)
  • Revvity (US)
  • SouthernBiotech (US)
  • Illumina, Inc. (US)
  • ImmunoPrecise Antibodies Ltd (US)
  • Fujirebio (Sweden)
  • Analytik Jena GmbH+Co. KG (Germany)
  • Omega Bio-tek, Inc. (US)
  • Dovetail Genomics (US)
  • Atlas Antibodies (Sweden)
  • Rockland Immunochemicals, Inc. (US)
  • Santa Cruz Biotechnology, Inc.(US)
  • Jackson ImmunoResearch Inc. (US)
  • Proteintech Group, Inc. (US)
  • ICL, Inc. (US)
  • and Among Others

Buy a Research Antibodies & Reagents Industry Report (385 Pages PDF with Insightful Charts, Tables, and Figures):

The study categorizes the Research Antibodies and Reagents market based on product, technology, application, end User and regional and global level.

Global Research Antibodies and Reagents Market, by Product                  

  • Reagent
    • Media & Sera
    • Stains & Dyes
    • Fixatives
    • Buffers
    • Solvents
    • Enzymes
    • Probes
    • Other Reagents
  • Antibodies
    • By Type
      • Primary Antibodies
      • Secondary Antibodies
    • By Form
      • Monoclonal
      • Polyclonal
      • Recombinant
    • By Source
      • Mice
      • Rabbits
      • Other Sources
    • By Research Area
      • Oncology
      • Infectious Diseases
      • Immunology
      • Neurobiology
      • Stem Cells
      • Other Research Areas

Global Research Antibodies and Reagents Market, by Technology

  • Western Blotting
  • Flow Cytometry
  • Enzyme-linked immunosorbent assay (ELISA)
  • Immunohistochemistry
  • Immunofluorescence
  • Immunoprecipitation
  • Other Technologies

Global Research Antibodies and Reagents Market, by Application

  • Proteomics
  • Drug Development
  • Genomics

Global Research Antibodies and Reagents Market, by End User

  • Pharmaceutical & Biotechnologies Industries
  • Academic & Research Institutions
  • Contract Research Organizations

Global Research Antibodies and Reagents Market, by region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • South Korea
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • RoLATAM
  • Middle East & Africa
    • Middle East
    • Africa

Request for FREE Sample Pages:

The key stakeholders in the Research Antibodies & Reagents market include:

  • Pharmaceutical and Biotechnology Companies
  • Research Laboratories
  • Life Sciences Companies
  • Academic Research Institutes
  • Government Institutes
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Venture Capitalists and Investors

Recent Developments:

  • In August 2023, Danaher (US) entered into a definitive agreement to acquire all the outstanding shares of Abcam plc (UK). Through this development, Abcam is expected to operate as a standalone operating company within Danaher’s Life Sciences segment.
  • In August 2023, Agilent Technologies, Inc. (US) announced the opening of a new full-scale Integrated Biology Center located at Monash University in Malaysia. The facility is focused on building local capabilities to accelerate research and development (R&D) in life science research.
  • In June 2023, Cell Signaling Technology, Inc. (US) and Lunaphore Technologies SA (Switzerland) have decided to partner to integrate CST antibodies into Lunaphore’s COMET platform for Spatial Biology research.

Frequently Asked Questions (FAQs) of Research Antibodies & Reagents Market:

Question 1. Who are the key players in the Research antibodies and reagents market?
Answer: Key players in the global research antibodies and reagents market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), BD (US), Agilent Technologies, Inc. (US), and Revvity (US).

Question 2: Which product type dominates in the research antibodies and reagents market?
Answer: The reagents segment dominated the research antibodies and reagents market product segment in 2022.

Question 3: Which application segment of the global research antibodies and reagents market is expected to witness the highest growth?
Answer: Drug development application segment is expected to witness the highest growth, attributed to increasing government and regulatory body investments.

Question 4: What is the market for research antibodies and reagents?
Answer: The global research antibodies and reagents market is projected to reach USD 16.2 billion by 2028 from USD 11.8 billion in 2023.

Question 5: What is the growth rate of the research antibodies and reagents market?
Answer: The global research antibodies and reagents market is expected to grow at 6.5% CAGR during the forecast period of 2023-2028.

Get 10% Free Customization on this Report:

Report Objectives:

  • To define, describe, segment, and forecast the global research antibodies and reagents market based on the product, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To forecast the size of the global research antibodies and reagents market in five main regions (along with countries)—North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa (MEA)
  • To profile key players in the global research antibodies and reagents market and comprehensively analyze their core competencies2 and market shares
  • To track and analyze competitive developments, such as product/technology development, partnerships, mergers, acquisitions, and expansions, and the R&D activities of the leading players in the research antibodies and reagents market
  • To benchmark players within the research antibodies and reagents market using the “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Related Reports:

Immunohistochemistry Market

Flow Cytometry Market

Custom Antibody Market

Digital PCR Market

Proteomics Market

Research Insight:

Content Source:

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy